The abstract is read at the publisher; the summary is JClub's.
Intestinal GPR128 deficiency protects mice from acetaminophen-induced liver injury, preserving goblet cell mucus-layer homeostasis and enriching mucus-associated Akkermansia muciniphila.
- Why it matters: Intestinal gene–microbe interactions that regulate acetaminophen-induced liver injury via the gut-liver axis are poorly defined, limiting targeted prevention strategies.
- What they did: Using intestinal GPR128-deficient mice challenged with acetaminophen, the study assessed liver injury, mucus integrity, microbiota composition, and microbial β-galactosidase activity, then tested A. muciniphila, dietary gentisic acid, and the HSP90α–CBFβ/RUNX1-UPP1 pathway with mouse, cellular, biochemical, and metabolic assays.
- The result: A. muciniphila-associated β-galactosidase promoted dietary gentisic acid liberation and increased systemic gentisic acid, which inhibited CBFβ nuclear translocation, suppressed RUNX1-dependent UPP1 transcription, reduced uridine-derived lactate production, and ameliorated acetaminophen-induced liver injury.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.